Organon Buys Rights to Certain Bayer Contraceptive Products in China
February 16 2022 - 9:34AM
Dow Jones News
By Michael Dabaie
Organon & Co. said it acquired the rights from Bayer AG to
Marvelon and Mercilon, combined oral hormonal daily contraceptive
pills, in the People's Republic of China, including Hong Kong and
Macau.
Organon said it also entered into an agreement to acquire the
rights to these products in Vietnam.
Marvelon and Mercilon are already owned, manufactured, and
marketed by Organon as prescription oral contraceptives in 20 other
markets. This acquisition gives Organon full global ownership of
these brands, except in South Korea, by reacquiring the rights to
them in these markets.
Organon said it expects the agreement to acquire the rights in
Vietnam to close in the first half of 2022.
Marvelon is currently available over the counter in China and
both Marvelon and Mercilon are available over the counter in Hong
Kong and Macau. Marvelon and Mercilon are currently available by
prescription in Vietnam.
Both contraceptives were acquired by Bayer AG in these markets
from Merck & Co. Inc. in 2014 as part of the sale of Merck
& Co.'s consumer care business. Organon was formed through a
spin-off from Merck.
Marvelon and Mercilon aren't available in the U.S.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
February 16, 2022 09:19 ET (14:19 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
